Shares of Zymeworks Inc. (ZYME) have gained 10.1% over the past four weeks to close the last trading session at $14.46, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $20.44 indicates a potential upside of 41.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $6.40. While the lowest estimate of $12 indicates a 17% decline from the current ...